I love hearing the stories of patients discharged within days. Just stop and think about that for a moment. People on death's door, getting discharged days later!! That is unheard of in medical practice.
Its been a hard slog, but MSB are so close now. Experienced bio-tech holders would have told you regulatory approval is a tricky hurdle, but few would have called the GvHD decision. It will be a temporary delay.
I am the recipient of two successful stem cell procedures (tenocyte stem cells in a tendon and mesenchymal in the shoulder labrum - cartilige/tendon mix so tenocyte stem cells inappropriate.
Within ten years tenocyte stem cells will be the gold start treatment for tendons, chondrocyte stem-cells for cartilige and mesenchymal stem-cells in a host of inflammatory and other conditions. Patients with unmet needs will have options. This is a watershed time in history that MSB will be the bastion of.
Ann: COVID-19 ARDS & GVHD Update, Quarterly Report & Appendix 4C, page-53
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.150(13.0%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.33 | $1.15 | $25.26M | 19.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 161000 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 50400 | 2 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |